Inventor · disambiguated record
Yousef Al-Abed
Also filed as: AL-ABED YOUSEF
37 granted patents·14 pending applications·195 citations·filing 1996–2023
97Inventor score
Files withFEINSTEIN INSTITUTES FOR MEDICAL RESEARCH11AL-ABED YOUSEF9THE FEINSTEIN INST MEDICAL RES8FEINSTEIN INST MEDICAL RES7PICOWER INST MED RES5
Top patents by PatentIndex Score
51 records- 0195US11471507B2HMGB1 antagonistFEINSTEIN INSTITUTES FOR MEDICAL RESEARCH·Filed 2020·Granted Oct 18, 2022·7 cites·20 claims
- 0294US11524048B2HMGB1 antagonist treatment of severe sepsisFEINSTEIN INSTITUTES FOR MEDICAL RESEARCH·Filed 2020·Granted Dec 13, 2022·3 cites·20 claims
- 0394US11471508B2HMGB1 antagonist treatment of diabetic peripheral neuropathyFEINSTEIN INSTITUTES FOR MEDICAL RESEARCH·Filed 2020·Granted Oct 18, 2022·4 cites·20 claims
- 0494US10919882B2Compounds for use in synthesis of peptidomimeticsFEINSTEIN INSTITUTES FOR MEDICAL RESEARCH·Filed 2020·Granted Feb 16, 2021·4 cites·21 claims
- 0591US11414405B2Compounds for use in synthesis of peptidomimeticsFEINSTEIN INSTITUTES FOR MEDICAL RESEARCH·Filed 2021·Granted Aug 16, 2022·2 cites·20 claims
- 0689US11883461B2HMGB1 antagonist treatment of severe sepsisFEINSTEIN INSTITUTES FOR MEDICAL RESEARCH·Filed 2022·Granted Jan 30, 2024·1 cites·10 claims
- 0789US11684652B2HMGB1 antagonist treatment of acute lung injuryFEINSTEIN INSTITUTES FOR MEDICAL RESEARCH·Filed 2020·Granted Jun 27, 2023·2 cites·17 claims
- 0887US11440881B2Thiosemicarbazates and uses thereofFEINSTEIN INSTITUTES FOR MEDICAL RESEARCH·Filed 2020·Granted Sep 13, 2022·4 cites·8 claims
- 0985US6492428B1Compounds having MIF antagonist activityPICOWER INST MED RES·Filed 2000·Granted Dec 10, 2002·23 cites·11 claims
- 1085US6380165B1Immunological advanced glycation endproduct crosslinkPICOWER INST MED RES·Filed 1997·Granted Apr 30, 2002·68 cites·3 claims
- 1182US7928130B2Isoxazoline compounds having MIF antagonist activityCYTOKINE PHARMASCIENCES INC·Filed 2009·Granted Apr 19, 2011·4 cites·5 claims
- 1280US6599938B1Compounds having MIF antagonist activityPICOWER INST OF MEDICAL RES·Filed 2000·Granted Jul 29, 2003·19 cites·15 claims
- 1379US8362053B2Modified macrophage migration inhibitory factor inhibitorsTHE FEINSTEIN INST MEDICAL RES·Filed 2007·Granted Jan 29, 2013·3 cites·17 claims
- 1478US12351573B2Compounds for use in synthesis of peptidomimeticsFEINSTEIN INSTITUTES FOR MEDICAL RESEARCH·Filed 2022·Granted Jul 8, 2025·0 cites·29 claims
- 1578US8741924B2Compounds and methods for treatment of systemic lupus erythematosusAL-ABED YOUSEF·Filed 2011·Granted Jun 3, 2014·2 cites·26 claims
- 1678US8207206B2(S,R)-3-phenyl-4,5 dihydro-5-isoxazole acetic acid-nitric oxide and use thereof as anti-cancer and antiviral agentNICOLETTI FERDINANDO·Filed 2008·Granted Jun 26, 2012·7 cites·8 claims
- 1777US7807696B2Isoxazole and isothiazole compounds useful in the treatment of inflammationTHE FEINSTEIN INST MEDICAL RES·Filed 2004·Granted Oct 5, 2010·8 cites·20 claims
- 1876US2023364181A1Treatment of hmgb1-mediated inflammationFEINSTEIN INST MEDICAL RES·Filed 2023·Application pending·0 cites
- 1973US10857197B2Treatment of HMGB1-mediated inflammationTHE FEINSTEIN INSTITUE FOR MEDICAL RES·Filed 2015·Granted Dec 8, 2020·2 cites·12 claims
- 2072US7662843B2Isoxazoline compounds having MIF antagonist activityCYTOKINE PHARMASCIENCES INC·Filed 2004·Granted Feb 16, 2010·4 cites·5 claims
- 2171US8552040B2Isoxazoline compounds having MIF antagonist activityAL-ABED YOUSEF·Filed 2011·Granted Oct 8, 2013·1 cites·2 claims
- 2271US8193247B2Phenolic hydrazone macrophage migration inhibitory factor inhibitorsAL-ABED YOUSEF·Filed 2007·Granted Jun 5, 2012·1 cites·20 claims
- 2370US11633450B2Treatment of HMGB1-mediated inflammationFEINSTEIN INST MEDICAL RES·Filed 2020·Granted Apr 25, 2023·0 cites·2 claims
- 2470US8618147B2Modified macrophage migration inhibitory factor inhibitorsAL-ABED YOUSEF·Filed 2013·Granted Dec 31, 2013·1 cites·6 claims
- 2570US7491740B2Isoxazoline compounds having MIF antagonist activityCYTOKINE PHARMASCIENCES INC·Filed 2002·Granted Feb 17, 2009·3 cites·6 claims
- 2669US8742173B2Phenolic hydrazone macrophage migration inhibitory factor inhibitorsAL-ABED YOUSEF·Filed 2012·Granted Jun 3, 2014·1 cites·11 claims
- 2764US2020277246A1Treatment method, compounds, and method of increasing trpv2 activityFEINSTEIN INST MEDICAL RES·Filed 2019·Application pending·0 cites
- 2862US9096576B2Compounds and methods for treatment of systemic lupus erythematosusTHE FEINSTEIN INST MEDICAL RES·Filed 2014·Granted Aug 4, 2015·0 cites·19 claims
- 2955US9457013B2Method for treating a neurological disorder associated with hypoxia using a small moleucule MIF inhibitorTHE FEINSTEIN INST MEDICAL RES·Filed 2014·Granted Oct 4, 2016·0 cites·12 claims
- 3055US5811401AAdvanced glycosylation endproducts and methods of use thereforPICOWER INST MED RES·Filed 1996·Granted Sep 22, 1998·16 cites·6 claims
- 3154US8563578B2Antitumor properties of NO modified protease inhibitorsNICOLETTI FERDINANDO·Filed 2009·Granted Oct 22, 2013·0 cites·5 claims
- 3253US2011201686A1Inhibitors of ASS and Synuclein AggregationAL-ABED YOUSEF·Filed 2007·Application pending·0 cites
- 3352US2020354404A1Peptidomimetic agents, synthesis and uses thereofFEINSTEIN INSTITUTES FOR MEDICAL RESEARCH·Filed 2020·Application pending·0 cites
- 3450US2011136911A1Treatment of sepsis and inhibition of mif by d-t4THE FEINSTEIN INST MEDICAL RES·Filed 2008·Application pending·0 cites
- 3549US8759376B2Isoxazole and isothiazole compounds useful in the treatment of inflammationAL-ABED YOUSEF·Filed 2010·Granted Jun 24, 2014·0 cites·14 claims
- 3649US2016296574A1Ephedra alata extracts and methods of use thereofMURAD OSAMA MANSOUR·Filed 2014·Application pending·0 cites
- 3748US2018098950A1Inhibitors of abeta and synuclein aggregationFEINSTEIN INST MEDICAL RES·Filed 2017·Application pending·0 cites
- 3847US9440914B2Method for treating glioblastomas and other tumorsTHE FEINSTEIN INST MEDICAL RES·Filed 2014·Granted Sep 13, 2016·0 cites·9 claims
- 3947US2023159450A1Dimers for use in synthesis of peptidomimeticsFEINSTEIN INSTITUTES FOR MEDICAL RESEARCH·Filed 2021·Application pending·0 cites
- 4046US2002193412A1Compounds and compositions for treating tissue ischemiaFiled 2002·Application pending·0 cites
- 4145US9567306B2Inhibition of macrophage migration inhibitory factor in melanoma and colon cancerTHE FEINSTEIN INST MEDICAL RES·Filed 2015·Granted Feb 14, 2017·0 cites·20 claims
- 4245US8741299B2Method for treating pathologies associated with hypoxia using MIF inhibitorsMILLER EDMUND·Filed 2012·Granted Jun 3, 2014·0 cites·11 claims
- 4345US2013317040A1Methods for treating systemic lupus erythematosus using hiv protease inhibitorsAL-ABED YOUSEF·Filed 2011·Application pending·0 cites
- 4445US2009318509A1Oxime Derivatives as Inhibitors of Macrophage Migration Inhibitory FactorAL-ABED YOUSEF·Filed 2007·Application pending·0 cites
- 4543US2018037528A1Treatment method, compounds, and method of increasing trpv2 activityFEINSTEIN INST MEDICAL RES·Filed 2016·Application pending·0 cites
- 4642US10144723B2Treatment of solid tumors by inhibiting MRK/ZAKFEINSTEIN INST MEDICAL RES·Filed 2015·Granted Dec 4, 2018·0 cites·17 claims
- 4741US2008305118A1Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory FactorTHE FEINSTEIN INST MEDICAL RES·Filed 2005·Application pending·0 cites
- 4840US5770571AMethod and agents for inhibiting protein agingPICOWER INST MED RES·Filed 1996·Granted Jun 23, 1998·3 cites·4 claims
- 4938US6391899B1Compounds and compositions for treating tissue ischemiaLONG ISLAND JEWISH RES INST·Filed 1998·Granted May 21, 2002·2 cites·25 claims
- 5037US2019262307A1Iguratimod as an mif inhibitorFEINSTEIN INST MEDICAL RES·Filed 2017·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yousef Al-Abed files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →